Search global stocks & ETFs...Ctrl K

Learn Mode

TMO - Thermo Fisher Scientific Inc

248

$451.79

$3.98 (0.889%)

At market close

$451.78

-$0.009 (-0.002%)

After Hours 5/20/26, 9:25 PM

Score

3.67/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

TMO

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$167.89B

Industry

Life Sciences Tools & Services

EPS (TTM)

$18.35

P/E (TTM)

24.52

Div & Yield

$1.88 (0.42%)

FCF Payout Ratio

10.36%

P/S (TTM)

3.71

P/B

3.23

Diluted Shares

373.00M

Ex-Dividend

2026-03-13

Next Earnings

07-21

Forward P/E

17.77

Payout Ratio

10.20%

P/FCF (TTM)

24.89

FCF Yield

4.02%

Earnings Yield

4.08%

52 Week Range

Score Card

Explore Scores Tab

3.67

Good

Thermo Fisher Scientific Inc has grown revenue at 5.36% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -1.58% over the past year, which suggests the company is buying back shares.

Valuation Model

Key Score

5.00

Very Good

Management

1.00

Very Bad

Growth

5.00

Very Good

Profitability

5.00

Very Good

Fin. Health

5.00

Very Good

Dividends

1.00

Very Bad

Analyst

4.00

Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

Filter Form Types

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-05-11 07:30:20

Form 10-Q

General form for quarterly financial reports under Section 13 or 15(d)

Filed on 2026-05-01 11:00:48

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-30 13:58:52

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-29 16:38:18

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-04-27 09:58:12

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-23 06:03:39

Form ARS

Unknown Form Type

Filed on 2026-04-07 08:16:49

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-04-07 08:16:00

Form DEF 14A

Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-04-07 08:14:21

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-31 17:03:55

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-31 17:02:36

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-31 17:01:14

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-05-11

High:

$787.50

74.3%

Avg:

$636.66

40.9%

Low:

$545.40

20.7%

(% change is relative to the current stock price: $451.79)

Analyst Recommendations

Go to Analyst Tab

4.21

Very Good

32%

Strong Buy (11)

56%

Buy (19)

12%

Hold (4)

Sell (0)

Strong Sell (0)

About

Website
https://corporate.thermofisher.com/us/en/index.html
Address
168 Third Avenue, Waltham MASSACHUSETTS, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=97745

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offer virtually everything needed for the laboratory. The company also provides purification and filtration technologies.

IPO Date

1980-08-27

Industry

Life Sciences Tools & Services

Total Employees

125,000

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Life Sciences Tools & Services

GICS Sub

Life Sciences Tools & Services

GICS Sector

Health Care

GICS Group

Pharmaceuticals, Biotechnology & Life Sciences

TMO - Thermo Fisher Scientific Inc

248

$451.79

$3.98 (0.889%)

$451.78

-$0.009 (-0.002%)

3.67/5

Stock Unlock

Stock Profile

Score Card

Good

Insider Transactions

Market News

Form DEFA14A

Filed on 2026-05-11 07:30:20

Form 10-Q

Filed on 2026-05-01 11:00:48

Form SCHEDULE 13G

Filed on 2026-04-30 13:58:52

Form 4

Filed on 2026-04-29 16:38:18

Form 144

Filed on 2026-04-27 09:58:12

Form 8-K

Filed on 2026-04-23 06:03:39

Form ARS

Filed on 2026-04-07 08:16:49

Form DEFA14A

Filed on 2026-04-07 08:16:00

Form DEF 14A

Filed on 2026-04-07 08:14:21

Form 4

Filed on 2026-03-31 17:03:55

Form 4

Filed on 2026-03-31 17:02:36

Form 4

Filed on 2026-03-31 17:01:14

Financials

Price Targets

74.3%

40.9%

20.7%

Analyst Recommendations

About

Similar Stocks